Movement Disorders (revue) - Curation (PubMed)

Index « MedMesh.i » - entrée « Amantadine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Alzheimer Disease < Amantadine < Ambulatory Care  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000559 (2014) Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. FacherisCombined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
000A78 (2013) Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins ; Kathryn A. Chung ; Robert A. Hauser ; Janis M. Miyasaki ; Anthony P. Nicholas ; Werner Poewe ; Klaus Seppi ; Olivier Rascol ; Mark A. Stacy ; John G. Nutt ; Caroline M. Tanner ; Alison Urkowitz ; Jean A. Jaglin ; Song GeWhich dyskinesia scale best detects treatment response?
000A93 (2013) Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
001021 (2012) R A Walsh ; A E LangMultiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.
001038 (2011) Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill ; Alan R. Crossman ; Paula RavenscroftSynergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.
001170 (2011) Olivier Rascol [France] ; Andres Lozano ; Matthew Stern ; Werner PoeweMilestones in Parkinson's disease therapeutics.
001761 (2010) Francisco De Assis Aquino Gondim ; Helida A. Costa ; Tauily C D. Taunay ; Gisele R. De Oliveira ; Jamile Magalhães Ferreira ; Francisco H. RolaTransient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
001919 (2010) Elisabeth Wolf [Autriche] ; Klaus Seppi ; Regina Katzenschlager ; Guenter Hochschorner ; Gerhard Ransmayr ; Petra Schwingenschuh ; Erwin Ott ; Iris Kloiber ; Dietrich Haubenberger ; Eduard Auff ; Werner PoeweLong-term antidyskinetic efficacy of amantadine in Parkinson's disease.
002040 (2008) Jordan S. Dubow ; Michael Rezak ; Andrew A. BermanReversible corneal edema associated with amantadine use: an unrecognized problem.
002480 (2008) Kenichi Kashihara [Japon] ; Takaki ImamuraAmantadine may reverse punding in Parkinson's disease--observation in a patient.
002511 (2007) Robert A. Hauser [États-Unis] ; Olivier Rascol ; Amos D. Korczyn ; A. Jon Stoessl ; Ray L. Watts ; Werner Poewe ; Peter P. De Deyn ; Anthony E. LangTen-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
002808 (2007) Dariusz Koziorowski [Pologne] ; Andrzej FriedmanLevodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
002B08 (2006) Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez ; Tom H. Johnston ; Donna Pires ; Valerie Voon ; Jonathan M. Brotchie ; Susan H. FoxPharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
002C17 (2006) Angela Deutschl Nder [Allemagne] ; Friedrich Asmus ; Elena Marelli ; Thomas Klopstock ; Thomas Gasser ; Kai BötzelExcellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
002C30 (2006) Rivka Inzelberg [Israël] ; Ubaldo Bonuccelli ; Edna Schechtman ; Ala Miniowich ; Rosa Strugatsky ; Roberto Ceravolo ; Chiara Logi ; Carlo Rossi ; Colin Klein ; J Martin RabeyAssociation between amantadine and the onset of dementia in Parkinson's disease.
002E26 (2006) Alexandre Gironell [Espagne] ; Jaime Kulisevsky ; Berta Pascual-Sedano ; David FlamarichEffect of amantadine in essential tremor: a randomized, placebo-controlled trial.
002F31 (2005) Anthony E. Lang [Canada]Treatment of progressive supranuclear palsy and corticobasal degeneration.
003082 (2005) Cheryl Waters [États-Unis]Other pharmacological treatments for motor complications and dyskinesias.
003084 (2005) Christopher G. Goetz [États-Unis] ; Werner Poewe ; Olivier Rascol ; Cristina SampaioEvidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
003086 (2005) Carlos Singer [États-Unis] ; Spiridon Papapetropoulos ; Manuel A. Gonzalez ; Eugene L. Roberts ; Abraham LiebermanRimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
003313 (2004) Yoshiaki Furukawa [Canada] ; James J. Filiano ; Stephen J. KishAmantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Amantadine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Amantadine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Amantadine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024